This a phase II study of new hormonal maneuvers in men with metastatic prostate cancer that has progressed after initial hormonal treatent. Patients may never have taken Casodex or aminoglutethimide. Patients must have been off Eulexin for at least 30 days.
Trial provides free monthly evaluations with a medical oncologist and study drug.
Patients blood will be analyzed for hormonal levels and a sample of tissue wil be obtained for molecular analysis. If you would like to learn more about participating in this study, please send an e-mail message using the form below. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research.